Body Weight Changes, Obesity, Overweight, Weight Change, Body, Weight Loss
Conditions
Keywords
Obesity, Overweight, Weight Loss, Body weight maintenance, Weight Change, Body, Saccharomyces Cerevisiae, Beta-glucans
Brief summary
Effect of the dietary supplement (FAT-BINDER DAMM) on weight regain after 9 months of control weight program
Detailed description
* 60 participants will consume experimental product every day 3 sticks of the dietary supplement (1.4 grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner. During the 12 first weeks, each volunteer will be included on a low weight program (PPP) with an individual hypocaloric diet planning and regular physical adapted activity (PPP period). When PPP period is over, volunteers will continue consuming the product for 9 months more (Post-PPP period). * 60 participants will consume everyday 3 placebo sticks (1.4 grams/stick) during 12 months: 2 sticks should be consumed before lunch and 1 stick before dinner. During the first 12 weeks, each volunteer will be included on a low weight program (PPP) with an individual hypocaloric diet planning and regular physical adapted activity (PPP period ). When PPP period is over, volunteers will continue consuming the product for 9 months more.
Interventions
3 sticks every day during 12 months
3 sticks every day during 12 months
Sponsors
Study design
Eligibility
Inclusion criteria
* Men and women ranging from 18 to 65 years old. * BMI ≥27 and \<40 kg/m2. Overweight type II, obesity type I and II * Social or familiar environment that prevents from accomplishing the dietary treatment. * Willingness to follow a balanced hypocaloric diet in order to lose weight and perform regular physical adapted activity. * Adequate cultural level and understanding of the clinical trial. * Signed informed consent.
Exclusion criteria
* Individuals diagnosed with Diabetes Mellitus type I. * Individuals diagnosed with Diabetes Mellitus type II on pharmacological treatment. * Individuals with dyslipidemia on pharmacological treatment. * Individuals with hypertension on pharmacological treatment uncontrolled. * Individuals allergic to yeast. * Individuals with chronic diseases (hepatic, kidney…). * Individuals who have participated in the last 6 months in a program or clinical trial to lose weight. * Individuals receiving at least the preceding 2 months a pharmacological treatment that modifies the lipid profile (for example, statins, fibrates, diuretics, corticosteroids, ADOs). * Pregnant or breastfeeding women.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Weight Regain | 12 months | Change from baseline in kilograms |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fat mass percentage | 12 months | Change from baseline in percentage |
| Body water percentage | 12 months | Change from baseline in percentage |
| Lean mass percentage | 12 months | Change from baseline in percentage |
| Triglycerides | 12 months | Change from baseline |
| Low density lipoprotein cholesterol | 12 months | Change from baseline |
| Body Mass Index (weight/height^2) | 12 months | Change from baseline in kg/m\^2 |
| Fiber | 12 months | Change from baseline |
| Satiety evaluation | [Just before eating the product; Just after eating; After 60 minutes; After 90 minutes] Fasting for at least 4 hours. Must do it with a snack accompanied and 500 ml water. | Visual Analog Scale to evaluate motivation-satiety when eating |
| 24 hours Dietary Recall | 12 months | 24 hours Food habits of overweight and obesity people |
| Sensory perception | Months 6, 7, 8 y 9. Gustatory and olfactory sensory perception of the subjects for the study products. | Questionnaire of analysis of sensory perception of the food study product. Five questions that are valued on a scale of 0% to 100% asking about the taste and smell of the study product: desire with which the product is taken, taste, smell, consistency and what wait for effectiveness. |
| International Physical Activity Questionnaire | 12 months | People physical activity habits |
| High density lipoprotein cholesterol | 12 months | Change from baseline |
Countries
Spain